➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Mallinckrodt
Merck
Baxter
AstraZeneca

Last Updated: July 23, 2021

DrugPatentWatch Database Preview

Pohl Boskamp Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for POHL BOSKAMP, and when can generic versions of POHL BOSKAMP drugs launch?

POHL BOSKAMP has three approved drugs.

There are two US patents protecting POHL BOSKAMP drugs.

There are nineteen patent family members on POHL BOSKAMP drugs in ten countries.

Summary for Pohl Boskamp
International Patents:19
US Patents:2
Tradenames:5
Ingredients:1
NDAs:3

Drugs and US Patents for Pohl Boskamp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pohl Boskamp NITROLINGUAL PUMPSPRAY nitroglycerin SPRAY, METERED;SUBLINGUAL 018705-002 Jan 10, 1997 AB RX Yes Yes 7,872,049 ⤷  Try it Free Y ⤷  Try it Free
Pohl Boskamp GONITRO nitroglycerin POWDER;SUBLINGUAL 208424-001 Jun 8, 2016 RX Yes Yes 9,101,592 ⤷  Try it Free Y ⤷  Try it Free
Pohl Boskamp NITRO IV nitroglycerin INJECTABLE;INJECTION 018672-002 Aug 30, 1983 DISCN No No ⤷  Try it Free ⤷  Try it Free
Pohl Boskamp NITRONAL nitroglycerin INJECTABLE;INJECTION 018672-001 Aug 30, 1983 DISCN No No ⤷  Try it Free ⤷  Try it Free
Pohl Boskamp NITROLINGUAL nitroglycerin AEROSOL;SUBLINGUAL 018705-001 Oct 31, 1985 DISCN No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for POHL BOSKAMP drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Sublingual Spray 400 mcg/spray, 4.9 g and 12 g bottles ➤ Subscribe 2012-08-23
➤ Subscribe Sublingual Spray 400 mcg/spray, 4.9 g and 12 g bottles ➤ Subscribe 2012-04-17

International Patents for Pohl Boskamp Drugs

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2012113564 ⤷  Try it Free
European Patent Office 2678000 ⤷  Try it Free
European Patent Office 2254552 ⤷  Try it Free
European Patent Office 2678006 ⤷  Try it Free
Spain 2672261 ⤷  Try it Free
Canada 2718345 ⤷  Try it Free
Poland 2678006 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
McKesson
Merck
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.